Predictors of participant engagement and naloxone utilization in a community‐based naloxone distribution program
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Aims: To describe characteristics of participants and overdose reversals associated with a community‐based naloxone distribution program and identify predictors of obtaining naloxone refills and using naloxone for overdose reversal. Design: Bivariate statistical tests were used to compare characteristics of participants who obtained refills and reported overdose reversals versus those who did not. We fitted multiple logistic regression models to identify predictors of refills and reversals; zero‐inflated multiple Poisson regression models were used to identify predictors of number of refills and reversals. Setting: San Francisco, California, USA. Participants: Naloxone program participants registered and reversals reported from 2010 to 2013. Measurements: Baseline characteristics of participants and reported characteristics of reversals. Findings: A total of 2500 participants were registered and 702 reversals were reported from 2010 to 2013. Participants who had witnessed an overdose [adjusted odds ratio (AOR) = 2.02, 95% confidence interval (CI) = 1.53–2.66; AOR = 2.73, 95% CI = 1.73–4.30] or used heroin (AOR = 1.85, 95% CI = 1.44–2.37; AOR = 2.19, 95% CI = 1.54–3.13) or methamphetamine (AOR = 1.71, 95% CI = 1.37–2.15; AOR = 1.61, 95% CI = 1.18–2.19) had higher odds of obtaining a refill and reporting a reversal, respectively. African American (AOR = 0.63, 95% CI = 0.45–0.88) and Latino (AOR = 0.65, 95% CI = 0.43–1.00) participants had lower odds of obtaining a naloxone refill, whereas Latino participants who obtained at least one refill reported a higher number of refills [incidence rate ratio (IRR) = 1.33 (1.05–1.69)]. Conclusions: Community naloxone distribution programs are capable of reaching sizeable populations of high‐risk individuals and facilitating large numbers of overdose reversals. Community members most likely to engage with a naloxone program and use naloxone to reverse an overdose are active drug users.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fisher, J. D., & Fisher, W. A. (1992) · Psychological Bulletin · doi:10.1037/0033-2909.111.3.455 · Cited by 2,459
Walley, A. Y., Xuan, Z., Hackman, H. H., Quinn, E., Doe-Simkins, M., Sorensen-Alawad, A., Ruiz, S., & Ozonoff, A. (2013) · BMJ · doi:10.1136/bmj.f174 · Cited by 999 · cited 1×
“programming, including an interrupted time–series analysis demonstrating a relative reduction in opioid overdose in communities that distributed naloxone compared to those that did not distribute naloxone [15,16].”
BackgroundFisher, W. A., Fisher, J. D., & Harman, J. (2003) · Social Psychological Foundations of Health and Illness · doi:10.1002/9780470753552.ch4 · Cited by 644 · cited 1×
“behavior, motivation to prevent future outcomes and skills to prevent or reverse outcomes [24,25].”
BackgroundIncidence, reversal, and prevention of opioid-induced respiratory depression
Dahan, A., Aarts, L., & Smith, T. W. (2010) · Anesthesiology · doi:10.1097/aln.0b013e3181c38c25 · Cited by 634
Calcaterra, S., Glanz, J., & Binswanger, I. A. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.11.018 · Cited by 330 · cited 1×
“7% world-wide between 1990 and 2013 [1], and drug overdose has been the largest cause of injury-related death among US adults since 2008 [2–4], a trend driven by increased opioid overdose mortality [5].”
BackgroundSaved by the nose: Bystander-administered intranasal naloxone hydrochloride for opioid overdose
Doe-Simkins, M., Walley, A. Y., Epstein, A., & Moyer, P. (2009) · American Journal of Public Health · doi:10.2105/ajph.2008.146647 · Cited by 250
Prescribing Naloxone to Actively Injecting Heroin Users: A Program to Reduce Heroin Overdose Deaths
Maxwell, S., Bigg, D., Stanczykiewicz, K., & Carlberg-Racich, S. (2006) · Journal of Addictive Diseases · doi:10.1300/j069v25n03_11 · Cited by 242
Cited by
McDonald, R., & Strang, J. (2016) · Addiction · doi:10.1111/add.13326 · Cited by 471
Opioid Overdose Prevention Programs Providing Naloxone to Laypersons - United States, 2014.
(2015) · PubMed Central · Cited by 426
Naloxone dosage for opioid reversal: current evidence and clinical implications
Rzasa Lynn, R., & Galinkin, J. (2018) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098617744161 · Cited by 346
Clinical Practice Guidelines for Pain Management in Acute Musculoskeletal Injury
Hsu, J. R., Mir, H., Wally, M. K., Seymour, R. B., & the Orthopaedic Trauma Association Musculoskeletal Pain Task Force (2019) · Journal of Orthopaedic Trauma · doi:10.1097/bot.0000000000001430 · Cited by 280
Rowe, C., Santos, G.-M., Vittinghoff, E., Wheeler, E., Davidson, P., & Coffin, P. O. (2016) · Journal of Urban Health · doi:10.1007/s11524-015-0023-8 · Cited by 80
Self-citation
Metadata
- Authors
- Rowe, C., Santos, G., Vittinghoff, E., Wheeler, E., Davidson, P., & Coffin, P. O.
- Venue
- Addiction
- Publisher
- Wiley
- Published
- 2015-07-14
- Volume
- 110
- Issue
- 8
- Pages
- 1301-1310
- ISSN
- 0965-2140 (ISSN-L)
- 1360-0443
- OpenAlex
- W1602761126
- Cited by
- 83
- References
- 8
- FWCI
- 5.18
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.